Feed AMRX
AM

Amneal Pharmaceuticals AMRX · NASDAQ

$19.36 +0.94% (+$0.18)

Market cap
$6.18B
Enterprise value
$8.85B
P/E
39.3x
Forward P/E
18.5x
PEG
-
P/S
2.0x
P/FCF
74.4x
EV/EBITDA
13.6x
ROIC
14.3%
Gross margin
39.3%
Net margin
5.0%
Dividend yield
-
Payout ratio
-
Net debt/EBITDA
4.1x
Beta
1.22
Free float
45.0%

About the company

Amneal Pharmaceuticals, Inc. is an American pharmaceutical company focused on the development, manufacturing, and distribution of generic and specialty medications. The company specializes in a broad range of therapeutic areas, including cardiovascular diseases, neurological disorders, oncology, and more. Amneal also produces its own branded products targeting specific conditions. The company is known for its ability to provide affordable medications while continuing to develop innovative therapies.

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

CEO

Chirag K. Patel

Employees

8,700

Headquarters

Bridgewater

Valuation

Is today's price reasonable?

Growth and estimates

Is it growing, and what comes next?

Profitability and quality

How much of the revenue is left, and how well does the company use its capital?

Financial health

Can it carry its debt?

Capital and dividends

What does the company do with the money it earns?

Analysts

What do the professionals think, and is it changing?

Owners and insiders

Who holds the stock, and what is management doing?

Segments

Which part of the company is growing?

Peer comparison

How does it compare with similar companies?

Price and risk

How does the stock behave?

Statements

Every number

We use essential cookies to run the website and optional analytics cookies to measure usage. See our Privacy Policy.